BML Capital Management, LLC is an institution, managing $110.6M across 19 long positions as of Q3 2025 with 89% Healthcare concentration, 93% concentrated in top 10 holdings, and 24% allocation to ACRS.
Largest long holdings in BML Capital Management, LLC's portfolio (92.7% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Medical - Diagnostics & Research Healthcare | $27.1M | 24.48% | — | 13.15% 14.3M shares | |
Biotechnology Healthcare | $21.7M | 19.60% | -$394.0K Sold | 9.42% 7.5M shares | |
Biotechnology Healthcare | $13.9M | 12.52% | — | 14.57% 3.1M shares | |
Biotechnology Healthcare | $11.5M | 10.42% | +$2.0M Bought | 9.56% 645.6K shares | |
Biotechnology Healthcare | $8.4M | 7.56% | +$221.7K Bought | 7.72% 3.2M shares | |
Biotechnology Healthcare | $7.4M | 6.70% | +$408.8K Bought | 9.99% 5.3M shares | |
Unknown Unknown | $4.8M | 4.37% | — | 1.16% 1.2M shares | |
Biotechnology Healthcare | $3.1M | 2.78% | — | 7.49% 2.0M shares | |
Biotechnology Healthcare | $2.8M | 2.54% | +$333.9K Bought | 9.84% 720.8K shares | |
Unknown Unknown | $1.9M | 1.73% | -$836.6K Sold | 2.27% 1.3M shares |
Portfolio activity, position movements, and quarter-over-quarter changes in BML Capital Management, LLC's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
New | |
+20.7% | |
+13.48% |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
Sold | |
Sold |
Portfolio insights and performance metrics for BML Capital Management, LLC
We use cookies for analytics. See our Privacy and Cookie Policy.